<DOC>
	<DOCNO>NCT01346215</DOCNO>
	<brief_summary>The purpose study investigate clinical non-inferiority , pharmacodynamic effect safety Actparin® ( heparin sodium - Laboratório Químico Farmacêutico Bergamo Ltd. ) compare Heparin Sodium ( APP Pharmaceuticals ) patient renal failure hemodialysis treatment .</brief_summary>
	<brief_title>Study Clinical Non-inferiority Actparin® ( Laboratorio Bergamo ) Compared Heparin Sodium ( APP Pharmaceuticals ) , Patients With Chronic Renal Failure</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients research agree participate study sign inform consent form ; Patients age 18 year , sex , regardless color social class ; Patients impair renal function chronic hemodialysis schedule least 3 time week give use heparin prophylaxis thrombosis system ; Patients laboratory result within specified acceptance criterion . Patients take part take part another clinical investigational study within 12 month ; Hypersensitivity heparin sodium and/or benzyl alcohol ; History active hemorrhage alteration blood coagulation , genetic disorder coagulation system ; History disease could aggravate terminate clinical manifestation , active peptic gastric ulcer ; Severe liver disease ; Patients cancer treatment ; Pregnant lactate woman ; Use glucocorticoids physiological dose ; Use anticoagulant ; Patients undergo surgery perform less 15 day ; History non response exacerbate response heparin sodium ; Patients adapt 150 UI/kg dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>heparin</keyword>
	<keyword>renal insufficiency , chronic</keyword>
	<keyword>extracorporeal dialysis</keyword>
	<keyword>fibrinolytic agent</keyword>
	<keyword>anticoagulant</keyword>
	<keyword>aPTT</keyword>
</DOC>